Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). (Q46338086)
Jump to navigation
Jump to search
scientific article published in October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). |
scientific article published in October 2008 |
Statements
1 reference
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). (English)
1 reference
Everett E Vokes
1 reference
Antonius A Miller
1 reference
Xiaofei F Wang
1 reference
Lin Gu
1 reference
Philip Hoffman
1 reference
Jamil Khatri
1 reference
Frank Dunphy
1 reference
Martin J Edelman
1 reference
Michael Bolger
1 reference
Mark R Green
1 reference
Cancer and Leukemia Group B (CALGB)
1 reference
1 October 2008
1 reference
3
1 reference
10
1 reference
1159-1165
1 reference